Apathy in Dementia Methylphenidate Trial 2
Public ClinicalTrials.gov record NCT02346201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02346201
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Other
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Methylphenidate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2015
- Primary completion
- Jul 14, 2020
- Completion
- Jul 14, 2020
- Last update posted
- Jun 12, 2023
2016 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | — |
| University of Arkansas | Little Rock | Arkansas | 72114 | — |
| Yale Alzheimer's Disease Research Unit | New Haven | Connecticut | 06510 | — |
| Emory | Atlanta | Georgia | 30322 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| University of Rochester | Rochester | New York | 14620 | — |
| Wake Forest | Winston-Salem | North Carolina | 27106 | — |
| University Hospitals- Case Medical Center | Cleveland | Ohio | 44106 | — |
| Roper-St. Francis Healthcare | Charleston | South Carolina | 29401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02346201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02346201 live on ClinicalTrials.gov.